• Multianimal MRI for Pancreatic Tumor Monitoring

  2026-08-17

  The reference study introduces a four-chamber MRI bed that enables high-resolution imaging of up to four pancreatic cancer-bearing mice in one acquisition session. In the KPC model, this workflow supports tumor detection, longitudinal measurement, trial enrollment, and proof-of-concept assessment of gemcitabine treatment while reducing imaging time and resource demands.

• Cyanine 3 Tyramide for Neural Signal Amplification

  2026-08-17

  Learn how Cyanine 3 Tyramide can convert low-abundance neural targets into microscopy-ready signals for IHC, ISH, and carefully controlled multiplex assays. This workflow connects the product to research on early life adversity, oxytocin signaling, and looming-evoked defensive behavior while emphasizing assay controls, optimization, and reproducibility.

• Collagen VI Scaffolds Mature iPSC-Derived Islet Organoids

  2026-08-16

  Zhu et al. show that decellularized amniotic membrane ECM improves the viability, architecture, endocrine function, and engraftment of iPSC-derived islet organoids. Their data identify collagen VI as a critical niche component and provide a biomimetic scaffold strategy for improving organoid-based diabetes research and transplantation.

• NSP15 Screening Identifies Thymopentin and Oleuropein

  2026-08-15

  The 2021 reference study used structure-based virtual screening and molecular dynamics to prioritize thymopentin and oleuropein as candidate inhibitors of SARS-CoV-2 NSP15. Its main contribution is a computationally supported strategy for targeting viral RNA-processing and immune-evasion machinery, while its findings still require biochemical, cellular, and infection-model validation.

• RSL3 Glutathione Peroxidase 4 Inhibitor Guide

  2026-08-14

  Learn how RSL3 converts GPX4 inhibition into a measurable ferroptosis workflow for cancer, redox, and aging-cell studies. This guide combines practical dosing, orthogonal readouts, rescue controls, and troubleshooting for models ranging from RAS-driven tumors to lens epithelium.

• 2'3'-cGAMP: A Causal Probe in Brain Injury

  2026-08-14

  Explore how 2'3'-cGAMP (sodium salt) can separate upstream DNA-sensing events from downstream STING competence in surgical brain injury models. This evidence-led guide translates NET–cGAS–STING findings into practical assay design and interpretation.

• Bufalin: Mechanism and Cancer Research Uses

  2026-08-13

  Bufalin is a cardiotonic steroid with documented apoptosis, differentiation, and protein-degradation activities in preclinical research. Recent evidence identifies STK33 as a Bufalin-binding target in triple-negative breast cancer models, while product documentation supports additional work on AP-1 signaling, estrogen receptor alpha, and hepatocellular carcinoma.

• Cy5 NHS ester(Et): Practical Labeling Guide

  2026-08-13

  Cy5 NHS ester(Et) is an amine-reactive, water-soluble fluorescent dye reagent for covalent labeling of proteins, peptides, and other biomolecules. It is suited to immunofluorescence, flow cytometry, and fluorescence microscopy workflows, but not to ethanol-based protocols or long-term storage of prepared solutions.

• From CpAdhE Biology to Natural Product Discovery

  2026-08-12

  A translational framework for using CpAdhE biology and the DiscoveryProbe™ Natural Product Library Plus to connect biochemical screening with antiparasitic lead discovery.

• Dimethyl Fumarate Suppresses cGAS–STING in Liver I/R

  2026-08-12

  The reference study identifies dimethyl fumarate as an inhibitor of STING-dependent signaling in hepatic ischemia–reperfusion injury. By combining DNA-triggered cell assays, mouse injury models, STING knockout animals, and immunocoprecipitation, the authors link DMF protection to reduced recruitment of TBK1 and IRF3 rather than to an autophagy-dependent mechanism.

• AI-Driven Prognostic Signature for Hepatocellular Carcinoma

  2026-08-11

  A multi-center study developed a seven-gene consensus artificial intelligence-derived prognostic signature by evaluating 101 machine-learning approaches across six hepatocellular carcinoma cohorts. The model linked risk scores with molecular dysregulation, likely treatment responsiveness, candidate drugs, and PITX1-Wnt/β-catenin biology, offering a framework for risk stratification that still requires prospective clinical validation.

• Norovirus Co-opts NINJ1 for Selective Protein Secretion

  2026-08-11

  Song and colleagues show that murine norovirus repurposes the membrane-rupture protein NINJ1 to release the viral immune-modulatory protein NS1 through an unconventional secretion route. Their genetic, cell-biological, mutational, and mouse infection experiments connect caspase-3 cleavage, NINJ1 recruitment, and selective viral protein release to enteric infection.

• RG108 DNA Methyltransferase Inhibitor Workflow

  2026-08-10

  RG108 provides a non-nucleosidic route to DNMT inhibition for cell-based methylation, expression, and tumor suppressor gene reactivation studies. This practical workflow connects concentration control, orthogonal readouts, and troubleshooting to help cancer research teams distinguish genuine epigenetic responses from solvent, viability, or assay artifacts.

• Griseofulvin: Microtubule Assay Workflows

  2026-08-09

  Build more informative antifungal experiments with Griseofulvin, a DMSO-soluble microtubule associated inhibitor suited to dose-response, imaging, and mechanism-focused workflows. This guide connects fungal growth phenotypes with a published aneugenicity assay framework while emphasizing solubility control, exposure design, and practical troubleshooting.

• PEGylated Iron Oxide Nanoparticles in the Liver

  2026-08-08

  This ACS Nano study systematically examines how iron oxide nanoparticle size and PEG chain length shape hepatic distribution and uptake by primary liver cell populations. Its central contribution is the integration of 99mTc-SPECT/CT with cell-specific in vitro analysis, showing that hepatocytes and stellate cells can contribute substantially to uptake and that the optimal PEG length may balance circulation with reduced hepatic sequestration.

16827 records 1/1122 page Next 12345 下5页 Last page